End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31 TWD | +5.98% | +2.99% | +4.20% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody New Drug
100.0
%
| 30 | 100.0 % | 3 | 100.0 % | -91.55% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
63.3
%
| 19 | 64.1 % | 2 | 63.3 % | -91.65% |
Taiwan
36.7
%
| 0 | 1.6 % | 1 | 36.7 % | +99.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mei Chun Yang
CEO | Chief Executive Officer | - | 06-12-31 |
Tong Hsuan Chang
FOU | Founder | - | 01-01-31 |
Dih Fen Wu
DFI | Director of Finance/CFO | - | 09-12-31 |
Yao Hua Lue
IRC | Investor Relations Contact | - | 12-11-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kao Chung Tsai
BRD | Director/Board Member | 62 | - |
Tong Hsuan Chang
FOU | Founder | - | 01-01-31 |
Ling-Chun Tsai
BRD | Director/Board Member | - | 12-05-24 |
Hsiu E. Su
BRD | Director/Board Member | - | - |
Tseng-Fu Chen
BRD | Director/Board Member | - | 12-05-24 |
Cai Qing Hong
BRD | Director/Board Member | - | - |
Zong Zheng Wu
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,640,100 | 89,098,133 ( 82.01 %) | 0 | 82.01 % |
Company contact information
GlycoNex, Inc.
8th Floor, Section 1 No. 97 Xintai 5th Road
221 75, New Taipei
+
http://www.glyconex.com.twSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+4.20% | 97.84M | |
+18.97% | 44.44B | |
+41.98% | 40.03B | |
-10.06% | 37.68B | |
+31.15% | 31.46B | |
-7.79% | 27.29B | |
+13.32% | 26.29B | |
+43.05% | 13.8B | |
+31.28% | 12.46B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- 4168 Stock
- Company GlycoNex Incorporation